4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC
Financial Results, Press Release
Ajay Dhankhar Appointed to Bioventus Inc. Board of Directors
Reports Third Quarter Financial Results
Reports Second Quarter Financial Results
News, Material Contracts
Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products
Shareholder votes
Reports First Quarter Financial Results
FY 2025
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Specialized Disclosure Report
Submission Upload
Correspondence
SEC Staff Correspondence